Clinical trial Recruiting at 1 site Interventional Ages 50 to 70

Mulligan Mobilization With Movement for improving ankle movement in type 2 diabetes

Official title: Comparative Effects of Mulligan Mobilization With Movement and Conventional Physiotherapy on Ankle Range of Motion, Mobility, Pain, and Quality of Life in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Run by Ibadat International University, Islamabad · NCT07827625 · Data updated 2026-11-12

This study tests whether Mulligan Mobilization with Movement can improve ankle motion, mobility, pain, and quality of life in people with type 2 diabetes who have limited ankle dorsiflexion.

Quick facts

Study typeInterventional
Ages50 Years to 70 Years
SexAll
Enrollment56 (estimated)
SponsorIbadat International University, Islamabad
Academic / other
Locations1 site (Islamabad, Federal)
StatusRecruiting
StartedMarch 2, 2026
Main results expectedSeptember 30, 2026
Study endsOctober 5, 2026
Registry record updatedSeptember 18, 2026
Trial IDNCT07827625 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 50–70 with type 2 diabetes of at least five years, ankle dorsiflexion ≤10°, and moderate pain (NPRS 3–7).

Probably not a fit

Patients without significant ankle stiffness or pain, or those with active foot ulcers or neuropathy, may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In people with type 2 diabetes, restricted ankle movement can worsen pain and daily function. The trial compares Mulligan Mobilization with Movement to conventional physiotherapy to see which approach better improves ankle dorsiflexion, overall mobility, pain levels, and quality of life. Eligible participants are adults aged 50–70 with diabetes for at least five years and limited ankle motion. The intervention involves active weight-bearing dorsiflexion with a sustained posterior glide to correct ankle positioning. Outcomes focus on changes in range of motion, pain scores, gait-related mobility, and perceived quality of life.

Why it matters

Potential benefit: If successful, participants may experience improved ankle motion, reduced pain, and better daily function and quality of life.

How similar studies have gone: Existing literature suggests MWM can benefit ankle mobility in various populations, but its effectiveness specifically in adults with diabetes requires confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 50-70 years
* Both male and female
* Diabetes Mellitus \> 5 years' duration
* Willing to participate and provide informed consent
* Pain rated between 3-7 on the Numeric Pain Rating Scale (NPRS)
* Ankle dorsiflexion range of motion ≤10° on goniometric assessment

Exclusion Criteria:

* History of recent lower-limb surgery, fracture, or dislocation (\<6 months)
* Active diabetic foot ulcer or Charcot foot
* Any inflammatory joint disease (e.g., rheumatoid arthritis)
* Congenital foot deformity
* Diagnosed diabetic peripheral neuropathy

Where it's running

  • Ibadat International University
    Islamabad, Federal, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Hafsah Arshad, PhD — Ibadat International University, Islamabad
  • Study coordinator: Nazish Jahangir, Master in MSK
  • Email: Nazishjehanger@gmail.com
  • Phone: 03125319484

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.